Most Read Articles
Jairia Dela Cruz, 2 days ago
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
11 Sep 2020
Men who use calcium channel blockers (CCBs) are at risk of developing prostate cancer, and the risk increases with the duration of CCB exposure, according to the results of a systematic review and meta-analysis.
06 Sep 2020
Type 2 diabetes mellitus patients taking proton pump inhibitors (PPIs) are at a higher risk of sustaining hip fractures, a recent study has found.
4 days ago
Osteoarthritis (OA) is the most common condition affecting the joints. Dr Lee Eu Jin, an Orthopaedic Surgeon from Liberty Orthopaedic Clinic at Mount Elizabeth Medical Centre, Singapore, shares his insights with Pearl Toh on how to manage OA in the primary care setting.


Beta-blockers less protective against stroke, mortality than other antihypertensives

29 Aug 2020

Treatment with beta-blockers confers significantly less protection against stroke and overall mortality compared with other antihypertensive medications, according to a meta-analysis.

“However, [beta-blockers] exhibit a substantial risk-reducing ability for all events when prescribed to lower blood pressure (BP) in patients with modest or more clear BP elevations, and therefore can be used as additional agents in hypertensive patients,” the investigators said.

Randomized trials comparing beta-blockers vs placebo/no-treatment/less-intensive treatment (BP-lowering trials) or beta-blockers vs other antihypertensive agents in patients with or without hypertension (comparison trials) were identified in electronic databases.

The investigators separately considered trials in hypertension, those without chronic heart failure (HF) or acute myocardial infarction (MI), and those with either chronic HF or acute MI among BP-lowering trials and according to baseline comorbidity. They also calculated seven fatal and nonfatal outcomes using random-effects model for BP-lowering or comparison trials.

Eighty-four BP-lowering or comparison trials comprising 165,850 patients met the eligibility criteria. Beta-blockers reduced the incidence of major cardiovascular events (risk ratio [RR], 0.85, 95 percent confidence interval [CI], 0.78–0.92) and all-cause mortality (RR, 0.81, 95 percent CI, 0.75–0.86) in 67 BP-lowering trials (n=68,478; mean follow-up, 2.5 years; baseline systolic BP/diastolic BP, 136/82 mm Hg).

When limiting the analysis to five trials that exclusively enrolled hypertensive patients (n=18,724; mean follow-up, 5.1 years; baseline systolic BP/diastolic BP, 163/94 mm Hg), BP showed a decrease of –10.5/–7.0 mm Hg along with a 22-percent (95 percent CI, 6–34) reduction in major cardiovascular events.

In 24 comparison trials (n=103,764; mean follow-up, 3.92 years), beta blockers appear to be less protective for stroke and all-cause death compared with other agents in all trials and in trials conducted exclusively in hypertensive patients (mean RR increase, 20 percent and 6 percent, respectively, for both cases).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 2 days ago
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
11 Sep 2020
Men who use calcium channel blockers (CCBs) are at risk of developing prostate cancer, and the risk increases with the duration of CCB exposure, according to the results of a systematic review and meta-analysis.
06 Sep 2020
Type 2 diabetes mellitus patients taking proton pump inhibitors (PPIs) are at a higher risk of sustaining hip fractures, a recent study has found.
4 days ago
Osteoarthritis (OA) is the most common condition affecting the joints. Dr Lee Eu Jin, an Orthopaedic Surgeon from Liberty Orthopaedic Clinic at Mount Elizabeth Medical Centre, Singapore, shares his insights with Pearl Toh on how to manage OA in the primary care setting.